- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04660578
A.Chohan Continuous Squeezing Suture (ACCSS) for Placenta Previa / Accreta (ACCSS)
A.Chohan Continuous Squeezing Suture (ACCSS) for Controlling Hemorrhage From the Lower Uterine Segment at the Cesarean Section for Placenta Previa / Accreta: a Case Series
Study Overview
Status
Intervention / Treatment
Detailed Description
Postpartum haemorrhage (PPH) has always been a prominent cause of maternal morbidity as well as mortality worldwide, with uterine atony as the leading cause and peripartum hysterectomy as the only definitive treatment option . Researchers are struggling throughout the years to find a treatment modality other than hysterectomy, which has least morbidity and potential to preserve fertility. In an attempt to find a non-radical treatment for PPH due to uterine atony, a novel uterine compression suture was introduced in 1997. The time then witnessed emergence of a series of its variants from all over the world which effectively lowered the incidence of peripartum hysterectomy from uterine atony.
Meanwhile the incidence of placenta praevia and placenta accreta spectrum disorder rose dramatically across the globe because of rising incidence of repeat caesarean sections. Placenta accreta spectrum has opened up a new era in the history of PPH, as forcible separation of adherent placenta leads to massive bleeding from placental bed. Peripartum hysterectomy has once again emerged as gold standard treatment for this variety of PPH with its overall morbidity of 40-50%, and mortality of 7-10% in case of placenta percreta. The fear of placental bed bleeding has led to the development of conservative managements like "leaving the placenta in situ approach" with its wide range of mild to severe, and serious morbidities. The conservative surgical techniques i.e. The triple P procedure, one step conservative surgery approach, have also used the concept of non-separation of placenta and have instead adopted resection of myometrium with placenta in situ. These surgeries involve devascularisation of deep pelvic / major abdominal vessels and ligation of complex arterial anastomosis making the procedure technically difficult. Moreover, the devascularisation is done under extensive and expensive interventional radiological equipment which places the procedures out of reach for the routine setups particularly in the under developed countries. Another conservative surgical technique i.e. stepwise surgical approach, which described separation of placenta also mainly relied upon devascularisation of pelvic organs by bilateral ligation of anterior branch of internal iliac artery rather than elaborating the details of technique of controlling haemorrhage at the actual bleeding site.
Three corners stones of uterine compression sutures have been described in literature i.e. simplicity, safety and efficacy and no such suturing technique so far is published. Hence, it's the time for innovation in the treatment of placenta praevia and PAS. In this study, we report our own experience of a conservative surgical technique i.e. A. Chohan Continuous Squeezing Suture (ACCSS) application in the lower uterine segment during caesarean section in profusely bleeding patients with placenta praevia and placenta accreta spectrum without involvement of urinary bladder and other pelvic organs. This surgical technique takes on the separation of placenta and describes a placental bed suturing without involvement of interventional radiology as well as ligation of deep pelvic vessels. The objective of this study is to assess the simplicity, safety and efficacy of this surgical technique in the management of PAS, with the intension to develop a simple, safe and effective alternative to hysterectomy.
Surgical Procedure:
After opening the abdomen, a transverse incision was given in the lower uterine segment after ascertaining the site of easy fetal access avoiding the placenta as far as possible. After the delivery of the baby, the uterus was exteriorized and routine uterotonics were given. The placenta was left in-situ and incision margins were held with Green-armitage forceps to minimize bleeding.
The urinary bladder was dissected away to allow suturing on the inner side of the lower uterine segment. Uterine arteries were ligated on both sides and any blood vessels on the way were secured immediately. The placenta was then removed completely.
Within the puddle of blood, the ring of internal os was identified with the index and middle finger of one hand and held with Babcock forceps with the other hand. On the exposed inner surface of the LUS, suturing was started from the left corner of uterine incision, taking multiple half cm bites through half-thickness of the tissue at half cm intervals to reach the outer half of ring of the internal os. The suture was then tied and knot secured causing squeezing of uterine tissue. From here onwards similar sutures were placed continuously at 1 cm distance till the right corner was reached, where the knot was secured. During suturing it was ensured that internal os remains patent. The continued pull on the suture caused the squeezing of the LUS and arrested bleeding from all sinuses present at the placental site. If the bleeding was seen on the posterior uterine wall, a similar suture was applied. It was started from the outer half of the posterior lip of the ring of the internal os and going up to the highest bleeding point on the posterior wall of the uterus, extending from the left to right end of the uterine incision.
Any left over bleeding points were secured with separate hemostatic sutures, Routine closure of the uterus was performed in two layers as in the lower segment cesarean section.
The hospital stay of the patients was 3-7 days. All patients were reviewed on 7th postoperative day and were inquired about the history of fever, abdominal pain and excessive vaginal bleeding. The character of vaginal discharge / lochia was noted and any urinary complaint recorded. Caesarean section wound was examined and stitches removed. Second follow up visit was at 6 weeks postpartum for similar assessment and record of lactation / menstruation status. Pelvic ultrasound was done on both visits to detect any pelvic organ abnormality and collection of blood or pus.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 54000
- King Edward Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All consenting patients at 32 weeks of gestation, with the diagnosis of placenta previa and placenta accreta spectrum without involvement of bladder and other pelvic organs.
- Woman who wished to conserve the uterus.
Exclusion Criteria:
- Patients were excluded from the study if an emergency cesarean section was done due to severe antepartum hemorrhage before the plan of surgery.
- Patients with Placenta accreta spectrum with bladder and/or other pelvic organ involvement.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Single Group
A.Chohan continuous squeezing suture (ACCSS); An Obstetrical procedure using half circle 40mm round body polyglactin 910 suture #1 (Vicryl plus by Ethicon®), for controlling hemorrhage from the lower uterine segment, in patients with placenta previa / accreta for the prevention of hysterectomy at cesarean section.
|
A. Chohan Continuous Squeezing Suture (ACCSS)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peripartum hysterectomy
Time Frame: 24 hours
|
Number of peripartum hysterectomies within the study group
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Application time of suture in minutes
Time Frame: within 20 minutes
|
Time taken by the surgeon to complete application of suture in minutes
|
within 20 minutes
|
Estimated blood loss
Time Frame: duration of surgery in minutes
|
Estimate of blood loss in milliliters (ml) within the duration of cesarean section
|
duration of surgery in minutes
|
Number of units of blood transfusions
Time Frame: First 24 hours
|
number of units of blood transfused intra-operatively and within first 24 hours
|
First 24 hours
|
Duration of stay of the participants in hospital in days
Time Frame: 7 days
|
Number of days the patient stays in hospital postoperatively
|
7 days
|
Number of patients requiring other conservative medical and surgical treatments
Time Frame: Duration of surgery in minutes
|
use of additional measures (oxytocin, tranexamic acid, prostaglandins, uterine packing, internal iliac artery ligation) to control intraoperative hemorrhage from the lower uterine segment
|
Duration of surgery in minutes
|
Number of patients with urinary bladder trauma and its complication
Time Frame: 6 weeks
|
Intraoperative urinary bladder damage or any complication arising from it within 6 weeks of surgery
|
6 weeks
|
Number of patients with secondary postpartum hemorrhage
Time Frame: 6 weeks
|
Hemorrhage in milliliters (ml) after 1st 24 hours and before 6 completed weeks of surgery
|
6 weeks
|
Prevalence of maternal mortality
Time Frame: 6 weeks
|
Number of mothers dying in relation to cesarean section within 6 completed weeks of surgery
|
6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Muhammad A Chohan, FRCOG, FCPS, King Edward Medical University, Lahore, Pakistan
Publications and helpful links
General Publications
- Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev. 2014 Feb 13;2014(2):CD003249. doi: 10.1002/14651858.CD003249.pub3.
- Ngwenya S. Postpartum hemorrhage: incidence, risk factors, and outcomes in a low-resource setting. Int J Womens Health. 2016 Nov 2;8:647-650. doi: 10.2147/IJWH.S119232. eCollection 2016.
- Dohbit JS, Foumane P, Nkwabong E, Kamouko CO, Tochie JN, Otabela B, Mboudou E. Uterus preserving surgery versus hysterectomy in the treatment of refractory postpartum haemorrhage in two tertiary maternity units in Cameroon: a cohort analysis of perioperative outcomes. BMC Pregnancy Childbirth. 2017 May 30;17(1):158. doi: 10.1186/s12884-017-1346-0.
- Yong S, Pradhan M. Intrauterine Gauze Packing in Primary Post Partum Hemorrhage following Caesarean section: A Clinical study. Nepal J Obstet Gynaecol. 2013;7(1):33-6.
- D D, Reginald P. Internal uterine tamponade. A Textb Postpartum Hemorrhage. 2006;263-7.
- B-Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol. 1997 Mar;104(3):372-5. doi: 10.1111/j.1471-0528.1997.tb11471.x.
- Selcuk I, Uzuner B, Boduc E, Baykus Y, Akar B, Gungor T. Step-by-step ligation of the internal iliac artery. J Turk Ger Gynecol Assoc. 2019 May 28;20(2):123-128. doi: 10.4274/jtgga.galenos.2018.2018.0124. Epub 2018 Nov 30.
- Wang CY, Pan HH, Chang CC, Lin CK. Outcomes of hypogastric artery ligation and transcatheter uterine artery embolization in women with postpartum hemorrhage. Taiwan J Obstet Gynecol. 2019 Jan;58(1):72-76. doi: 10.1016/j.tjog.2018.11.014.
- Lee HY, Shin JH, Kim J, Yoon HK, Ko GY, Won HS, Gwon DI, Kim JH, Cho KS, Sung KB. Primary postpartum hemorrhage: outcome of pelvic arterial embolization in 251 patients at a single institution. Radiology. 2012 Sep;264(3):903-9. doi: 10.1148/radiol.12111383. Epub 2012 Jul 24.
- Matsubara S, Yano H, Ohkuchi A, Kuwata T, Usui R, Suzuki M. Uterine compression sutures for postpartum hemorrhage: an overview. Acta Obstet Gynecol Scand. 2013 Apr;92(4):378-85. doi: 10.1111/aogs.12077. Epub 2013 Feb 9.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 497/RC/KEMU
- SMDC/SMRC/97-19 (Other Identifier: Sharif Medical and Dental College, Lahore, Pakistan)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Placenta Accreta
-
Kasr El Aini HospitalUnknownPlacenta Accreta in Placenta Previa Anterior
-
Ain Shams Maternity HospitalCompleted
-
Maternal and Child Health Hospital of FoshanWithdrawnPlacenta Accreta SpectrumChina
-
Sohag UniversityRecruiting
-
Necmettin Erbakan UniversityRecruitingPlacenta Accreta, Third TrimesterTurkey
-
Ain Shams UniversityNot yet recruiting
-
Ain Shams UniversityUnknownPlacenta Accreta, Third TrimesterEgypt
-
HaEmek Medical Center, IsraelTechnion, Israel Institute of TechnologyUnknown
-
Hatem AbuHashimCompletedPlacenta Accreta SpectrumEgypt
-
Hatem AbuHashimUnknownPlacenta Accreta Spectrum
Clinical Trials on ACCSS
-
Sharif Medical Research CenterRecruitingPlacenta AccretaPakistan